These results show that MART‐1 protein‐expressing tumor SK‐MEL‐5 and Malme‐3M generate MHC I/P26‐35 complexes, which are recognized by MART‐1‐specific HLA‐A*02‐restricted CD8+ T cells. The gene discussed is HLA-A; the disease is neoplasm.